Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study

This publication has 17 references indexed in Scilit:

• Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.
  Diabetes Care, 2000
• Rosiglitazone
  Drugs, 1999
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• Mechanisms and clinical effects of thiazolidinediones
  Expert Opinion on Investigational Drugs, 1997
• Prevention of Complications in Non-Insulin-Dependent Diabetes Mellitus (NIDDM)
  Drugs, 1995
• Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study
  Diabetes Research and Clinical Practice, 1995
• Thiazolidine Derivatives Ameliorate High Glucose-induced Insulin Resistance via the Normalization of Protein-tyrosine Phosphatase Activities
  Journal of Biological Chemistry, 1995
• Oral Hypoglycemic Agents
  New England Journal of Medicine, 1989
• Characteristics of non-insulin-dependent diabetic patients with secondary failure to oral antidiabetic therapy
  The American Journal of Medicine, 1989
• Mechanism of Action of Sulphonylureas with Special Reference to the Extrapancreatic Effect: An Overview
  Diabetic Medicine, 1988